COMP <GO>
ALTG vs TMO // EV/EBITDA & P/E VALUATION
Alta Equipment Group Inc. (Class A) (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: ALTG 4
— TMO 7
▲ EV/EBITDA & P/E VALUATION LEADER: ALTG
LAST: $7.60 (+2.98%) • MKT CAP: $248.3M
valuation
23.0x
LAST: $709.18 (+0.71%) • MKT CAP: $262.22B
valuation
30.4x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ALTG VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ALTG | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 25.90% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 4.00% | 9.30% | -5.30 | TMO | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 23.0x | 30.4x | -7.40 | ALTG | /valuation <GO> |
| Free Cash Flow Yield | 9.59% | 2.40% | +7.19 | ALTG | /fcf-yield <GO> |
| Operating Margin | 1.30% | 17.40% | -16.10 | TMO | /operating-margins <GO> |
| Net Profit Margin | -4.40% | 15.10% | -19.50 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | -2.20% | 3.90% | -6.10 | TMO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.21% | 0.24% | +0.97 | ALTG | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.49 | 4.50 | -3.01 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 8/9 | -3.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 65.3 | 62.9 | +2.37 | ALTG | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.94 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 36.3x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $248.3M | $262.22B | -$261.97B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ALTG REV | TMO REV | ALTG GROSS % | TMO GROSS % | ALTG FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.84B | $44.56B | 25.9% | — | $23.8M | $6.29B |
| FY 2024 | $1.88B | $42.88B | 26.3% | — | $41.6M | $7.27B |
| FY 2023 | $1.88B | $42.86B | — | — | $58.4M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ALTG // BETA —
TMO // BETA 0.94